Mutations in HFE Causing Hemochromatosis Are Associated with Primary Hypertriglyceridemia

被引:23
作者
Solanas-Barca, Maria
Mateo-Gallego, Rocio
Calmarza, Pilar
Jarauta, Estibaliz
Bea, Ana M.
Cenarro, Ana
Civeira, Fernando [1 ]
机构
[1] Hosp Univ Miguel Servet, Unidad Lipidos, Inst Aragones Ciencias Salud I CS, Zaragoza 50009, Spain
关键词
METABOLIC SYNDROME; FAMILIAL HYPERTRIGLYCERIDEMIA; RISK; DISEASE; FERRITIN; TRIGLYCERIDES; POPULATION; ATHEROSCLEROSIS; HYPERLIPIDEMIA; PREVALENCE;
D O I
10.1210/jc.2009-0814
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context: Most cases of primary hypertriglyceridemia (HTG) are caused by the interaction of unknown polygenes and environmental factors. Elevated iron storage is associated with metabolic syndrome, diabetes, and obesity, and all of them are associated with HTG. Objective: The aim of the study was to analyze whether HFE mutations causing hereditary hemochromatosis (HH) are associated with primary HTG. Design: Genetic predisposition to HH was analyzed in a case-control study. Setting: The study was conducted at University Hospital Lipid Clinic. Participants: We studied two groups: 1) the HTG group, composed of 208 patients; and 2) the control group, composed of 215 normolipemic subjects and 161 familial hypercholesterolemia patients. Intervention: Two HFE mutations (C282Y and H63D) were analyzed. Main Outcome Measure: We measured HH genetic predisposition difference between groups. Results: HH genetic predisposition was 5.9 and 4.4 times higher in the HTG group than in the normolipemic (P = 0.02) and FH (P = 0.05) subjects, respectively. There were 35 cases (16.8%) of iron overload in the primary HTG group, 14 (6.5%) and nine (5.6%) in the normolipidemic and FH groups, respectively. A higher HH genetic predisposition and a different prevalence of iron overload in subjects with HH genetic predisposition among groups contributed to this higher prevalence. None of the four cases with the HFE genotype associated with high risk of HH in the control groups presented iron overload; however, in eight of 11 subjects (72.7%) with primary HTG and HH genetic predisposition, the iron overload was present. Conclusion: Mutations in HFE gene, favoring iron overload and causing HH, could play an important role in the development of several phenotypes of primary HTG. (J Clin Endocrinol Metab 94: 4391-4397, 2009)
引用
收藏
页码:4391 / 4397
页数:7
相关论文
共 39 条
[1]
Hemochromatosis and iron-overload screening in a racially diverse population [J].
Adams, PC ;
Reboussin, DM ;
Barton, JC ;
McLaren, CE ;
Eckfeldt, JH ;
McLaren, GD ;
Dawkins, FW ;
Acton, RT ;
Harris, EL ;
Gordeuk, VR ;
Leiendecker-Foster, C ;
Speechley, M ;
Snively, BM ;
Holup, JL ;
Thomson, E ;
Sholinsky, P ;
Acton, RT ;
Barton, JC ;
Dixon, D ;
Rivers, CA ;
Tucker, D ;
Ware, JC ;
McLaren, CE ;
McLaren, GD ;
Anton-Culver, H ;
Baca, JA ;
Bent, TC ;
Brunner, LC ;
Dao, MM ;
Jorgensen, KS ;
Kuniyoshi, J ;
Le, HD ;
Masatsugu, MK ;
Meyskens, FL ;
Morohashi, D ;
Nguyen, HP ;
Panagon, SN ;
Phung, C ;
Raymundo, V ;
Ton, T ;
Walker, AP ;
Wenzel, LB ;
Ziogas, A ;
Adams, PC ;
Bloch, E ;
Chakrabarti, S ;
Fleischhauer, A ;
Harrison, H ;
Jia, K ;
Larson, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1769-1778
[2]
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease [J].
Aigner, Elmar ;
Theurl, Igor ;
Theurl, Milan ;
Lederer, Dieter ;
Haufe, Heike ;
Dietze, Otto ;
Strasser, Michael ;
Datz, Christian ;
Weiss, Guenter .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (05) :1374-1383
[3]
Iron-overload-related disease in HFE hereditary hemochromatosis [J].
Allen, Katrina J. ;
Gurrin, Lyle C. ;
Constantine, Clare C. ;
Osborne, Nicholas J. ;
Delatycki, Martin B. ;
Nicoll, Amanda J. ;
McLaren, Christine E. ;
Bahlo, Melanie ;
Nisselle, Amy E. ;
Vulpe, Chris D. ;
Anderson, Gregory J. ;
Southey, Melissa C. ;
Giles, Graham G. ;
English, Dallas R. ;
Hopper, John L. ;
Olynyk, John K. ;
Powell, Lawrie W. ;
Gertig, Dorota M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (03) :221-230
[4]
Assmann G, 1998, EUR HEART J, V19, pA2
[5]
Fatty liver-based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia [J].
Brouwers, Martijn C. G. J. ;
van Greevenbroek, Marleen M. J. ;
Bilderbeek-Beckers, Monique A. L. ;
Robertus-Teunissen, Margee G. ;
van der Kallen, Carla J. H. ;
Stehouwer, Coen D. A. ;
de Bruin, Tjerk W. A. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (10) :1311-1317
[6]
Frequency of Low-Density Lipoprotein Receptor Gene Mutations in Patients With a Clinical Diagnosis of Familial Combined Hyperlipidemia in a Clinical Setting [J].
Civeira, Fernando ;
Jarauta, Estibaliz ;
Cenarro, Ana ;
Garcia-Otin, Angel L. ;
Tejedor, Diego ;
Zambon, Daniel ;
Mallen, Miguel ;
Ros, Emilio ;
Pocovi, Miguel .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (19) :1546-1553
[7]
Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study [J].
Dotevall, A ;
Johansson, S ;
Wilhelmsen, L ;
Rosengren, A .
DIABETIC MEDICINE, 2004, 21 (06) :615-622
[8]
Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults [J].
Ford, Earl S. ;
Li, Chaoyang ;
Pearson, William S. ;
Mokdad, Ali H. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (06) :572-578
[9]
Gómez-Gerique JA, 1999, MED CLIN-BARCELONA, V113, P730
[10]
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421